Latest News and Press Releases
Want to stay updated on the latest news?
-
VILLA GUARDIA (COMO), Italy, Dec. 12, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced that an oral presentation on Defibrotide was presented today at the 53nd...
-
VILLA GUARDIA (COMO), Italy, Dec. 8, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced changes to its Board of Directors, as a result of the resignation of Mr....
-
VILLA GUARDIA (COMO), Italy, Nov. 29, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced that an oral presentation on Defibrotide will be presented at the 53nd...
-
VILLA GUARDIA, Italy, Nov. 22, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced the establishment of a wholly owned subsidiary Gentium GmbH, located in Zug,...
-
Defibrotide product sales increased by 24% Product sales of EUR 16.02 million for the nine-months ended September 30, 2011 Cash flow positive On target with revised projected...
-
VILLA GUARDIA, Italy, Oct. 20, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today provided an update on the European Marketing Authorization Application for Defibrotide (the...
-
VILLA GUARDIA, Italy, Oct. 4, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced that Dr. Massimo Iacobelli has left his position as Senior Vice-President and...
-
Cash flow positive and stronger cash position Defibrotide product sales increased by 25% Net income of EUR 2.67 million (US$ 3.85 million) for the first half of 2011 Decrease in API...
-
VILLA GUARDIA (COMO), Italy, Sept. 14, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced that it will publish financials for the first half of 2011 on Tuesday,...
-
VILLA GUARDIA (COMO), Italy, Aug. 17, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced that it has voluntarily withdrawn the New Drug Application (NDA) for...